COMMUNIQUÉS West-GlobeNewswire

MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna
23/12/2017
PORTLAND, Ore. and CAMBRIDGE, Mass., Dec. 22, 2017 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a diagnostics company that enables the development and commercialization of precision medicines in oncology, announced [...]
Kalytera Announces Approval of Shares for Services and Settlement of Debt Transaction with The Salzman Group of Israel
22/12/2017
SAN FRANCISCO and TEL AVIV, Israel, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the TSX Venture Exchange (“ TSXV [...]
Portola Pharmaceuticals Provides Update on Biologics License Application (BLA) for AndexXa® (andexanet alfa)
22/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the U.S. Food and Drug Administration (FDA) will extend its review of the Biologics [...]
MPX Closes Oversubscribed Private Placement Offering of $26.5 Million
22/12/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) -- (CSE:MPX) (OTC:MPXEF) MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE: [...]
Novartis drug Tasigna® is approved by FDA as first and only CML therapy with Treatment-free Remission data in its label
22/12/2017
Inclusion of Treatment-free Remission (TFR) data provides additional and novel option in management of Ph+ CML-CP Deep and sustained molecular response included as key eligibility criteria for attempting TFR after [...]
Aeterna Zentaris Provides Update on Litigation against David Dodd and Philip Theodore
22/12/2017
CHARLESTON, S.C., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (the “Company” or “Aeterna Zentaris”) (NASDAQ: AEZS ) (TSX: AEZS ), a specialty biopharmaceutical company engaged in developing and [...]
ATW Tech Completes a Private Placement of Units of $423,640
22/12/2017
MONTREAL, Dec. 22, 2017 (GLOBE NEWSWIRE) -- AtmanCo inc. (“AtmanCo” or the “Company”) (TSX-V: ATW ) is pleased to announce the closing of a private placement consisting of the issuance of 3 530 333 units at a price of $ [...]
ATW Tech complète un placement privé d’unités de 423 640 $
22/12/2017
MONTRÉAL, 22 déc. 2017 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo Inc. » ou la « Société ») (TSX CROISSANCE:ATW) annonce aujourd'hui la clôture d’un placement privé de 423 640 $ par l’émission de 3 530 333 unités au prix [...]
Abattis Provides Company Update and Comments on LOI Regarding Green Tree Therapeutics
22/12/2017
VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to provide a company update and further commentary on its [...]
PSI Raises Record Amount for Charity at its 20th Annual Golf Tournament
22/12/2017
ARLINGTON, Va., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI), a leading provider of Health IT solutions to the federal government, is pleased to announce that it raised a record for [...]
NEOVACS : AVIS AUX PORTEURS DE BSA NEOVACS 2017 (FR0013275971) MODALITES D'AJUSTEMENT LEGAL ET CONTRACTUEL
22/12/2017
AVIS AUX PORTEURS DE BSA NEOVACS 2017 (FR0013275971) MODALITES D'AJUSTEMENT LEGAL ET CONTRACTUEL Paris, le 22 décembre 2017 -19h00 CET -NEOVACS (Euronext Growth Paris : ALNEV) fait savoir que les bons de souscription [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
22/12/2017
Company Release no. 25/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 December 2017 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
22/12/2017
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Cannabis Wheaton Income Corp. Announces Signing of Definitive Agreement With Streaming Partner CannTx Life Sciences Inc.
22/12/2017
VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that further to its [...]
Biotricity Closes a Registered Direct Financing and Paves the Way for Bioflux Launch
22/12/2017
REDWOOD CITY, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
Cannabis Wheaton Income Corp. Announces Private Placement of Convertible Debenture Units and Conversion of Prior Convertible Debenture Units
22/12/2017
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]
American Health Council Appoints Tamra Ward MSN, ARNP, NP-C, CHFN, CCTC to its Nursing Board
22/12/2017
NEW YORK, Dec. 22, 2017 (GLOBE NEWSWIRE) -- The American Health Council Board of Nurses welcomes Tamra Ward MSN, ARNP, NP-C, CHFN, CCTC as an affiliate. With an extensive 38 years within the healthcare industry, [...]
BioCorRx Recovery Program Used in Lieu of Conviction in Ohio
22/12/2017
ANAHEIM, CA, Dec. 22, 2017 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that that [...]
Canada House Wellness Group’s Intended Uses of Funds from Recently Closed $8.6 Million Convertible Debenture Unit Financing
22/12/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]

Pages